title: Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group.
authors.forename: M
authors.initials: M
authors.lastname: Hommel
authors.forename: J P
authors.initials: JP
authors.lastname: Boissel
authors.forename: C
authors.initials: C
authors.lastname: Cornu
authors.forename: F
authors.initials: F
authors.lastname: Boutitie
authors.forename: K R
authors.initials: KR
authors.lastname: Lees
authors.forename: G
authors.initials: G
authors.lastname: Besson
authors.forename: D
authors.initials: D
authors.lastname: Leys
authors.forename: P
authors.initials: P
authors.lastname: Amarenco
authors.forename: M
authors.initials: M
authors.lastname: Bogaert
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy*; D004311:Double-Blind Method; D005060:Europe; D005500:Follow-Up Studies; D006801:Humans; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D013300:Streptokinase